1. Home
  2. MAX vs PHAR Comparison

MAX vs PHAR Comparison

Compare MAX & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

HOLD

Current Price

$8.07

Market Cap

516.4M

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.27

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAX
PHAR
Founded
2014
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
516.4M
1.2B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MAX
PHAR
Price
$8.07
$12.27
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$12.70
$38.33
AVG Volume (30 Days)
572.7K
10.1K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
25.81
N/A
EPS
0.21
N/A
Revenue
$1,113,600,000.00
N/A
Revenue This Year
$13.42
$10.04
Revenue Next Year
$8.16
$2.51
P/E Ratio
$38.45
$3,041.22
Revenue Growth
28.78
N/A
52 Week Low
$7.09
$9.54
52 Week High
$13.92
$21.34

Technical Indicators

Market Signals
Indicator
MAX
PHAR
Relative Strength Index (RSI) 34.83 31.36
Support Level $7.09 $11.83
Resistance Level $10.26 $17.29
Average True Range (ATR) 0.49 0.44
MACD -0.14 -0.33
Stochastic Oscillator 4.67 22.05

Price Performance

Historical Comparison
MAX
PHAR

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: